Tendyne Holdings' Series C Round

Tendyne Holdings raised a round of funding on April 09, 2014.

Tendyne provides a transcatheter mitral valve replacement prosthesis for the treatment of both functional and degenerative mitral regurgitation. Its mitral valve is deployed and secured while preservi…

Articles about Tendyne Holdings' Series C Round: